Compare Baxter International Inc (BAX) vs ClearPoint Neuro Inc (CLPT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs ClearPoint Neuro Inc — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.36B), while ClearPoint Neuro Inc trades at $14.92 (market cap $444.14M). The key difference: Baxter International Inc is far larger — about 32.3× ClearPoint Neuro Inc's market cap, and Baxter International Inc pays a 0.14% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| BAX | CLPT | |
|---|---|---|
Market Cap | $14.36B | $444.14M |
Sector | Health | Health |
52-Week High | $28.35 | $29.60 |
52-Week Low | $15.80 | $8.66 |
Enterprise Value | $21.88B | $478.72M |
Dividend Yield | 0.14% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ClearPoint Neuro (CLPT) trades at $14.21, up 6.12% today, amid mixed technical signals and challenging fundamentals. The company reported Q2 2026 revenue growth but missed earnings expectations with a loss of $0.38 per share, continuing a trend of negative profitability. Despite 100% analyst buy ratings, financial metrics show significant losses with a net income margin of -81.76% and negative cash flow from operations of $30 million projected for 2026.
The investment case hinges on regulatory progress and partnership developments in neurotechnology, but substantial execution risks and persistent losses present headwinds. While analyst consensus remains bullish on long-term potential, current financial performance suggests cautious optimism is warranted until profitability improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →
